A comparison of cardiovascular disease risk factor biomarkers in African Americans and Yoruba Nigerians

Ethnicity and Disease

Volumn 18, Issue 4, 2008, Pages 427-433

  Deeg, M ^a,c,e   Baiyewu, O ^d   Gao, S ^a   Ogunniyi, A ^d   Shen, J ^a   Gureje, O ^d   Taylor, S ^a   Murrell, J ^a   Unverzagt, F ^b   Smith Gamble, V ^b,c   Evans, R ^a   Dickens, J ^b   Hendrie, H ^b   Hall, Kathleen S ^b  

^a Department of Medicine ^*  (United States)

^b INDIANA UNIVERSITY   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

African Americans; Biomarkers; Cardiovascular risk; Nigerians

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FOLIC ACID; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; LIPID;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NIGERIA; AGED; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DIET; ETHNOLOGY; LONGITUDINAL STUDY; NEGRO; OXIDATIVE STRESS; RISK FACTOR; UNITED STATES;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DIET; E-SELECTIN; FEMALE; HUMANS; INDIANA; LIPIDS; LONGITUDINAL STUDIES; MALE; NIGERIA; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS;

EID: 59849092565     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547-3553.
2. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398-1405. (Pubitemid 40523734)
3. Alberts M, Urdal P, Steyn K, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil. 2005;12(4):347-354. (Pubitemid 41192166)
4. Sekikawa A, Horiuchi BY, Edmundowicz D, et al. A "natural experiment" in cardiovascular epidemiology in the early 21st century. Heart. 2003;89(3):255-257.
5. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112(23):3554-3561. (Pubitemid 43739532)
6. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004;61(5):705-714. (Pubitemid 38637688)
7. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65(4):545-551. (Pubitemid 41170713)
8. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556-1560. (Pubitemid 41434560)
9. Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry. 1995;152(10):1485-1492.
10. Szwast S, Hendrie HC, Lane KA, et al. Statin use reduces cognitive decline in elderly African Americans. Mechanism of action is unclear. Neurology. 2007;69(19):1873-1880.
11. NDS Software: Created with Nutrition Data System for Research (NDS-R), Database Version 4.02 30 1999 Regents of the University of Minnesota.
12. Olusanya EO. Manual on Food Consumption Surveys in Developing Countries. Ibadan (Nigeria): Ibadan University Press; 1977.
13. Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006;20(3 Suppl 2):S42-6. (Pubitemid 44265849)
14. Hall KS, Murrell J, Ogunniyi A, et al. Cholesterol, APOE genotype and Alzheimer's disease: an epidemiological study of Nigerian Yoruba. Neurology. 2006;66:223-227.
15. Evans RM, Emsley CL, Gao S, et al. Serum cholesterol, APOE genotype and the risk of Alzheimer disease in a population-based study of African Americans. Neurology. 2000;54:240-242.
16. Midorikawa S, Sanada H, Hashimoto S, Watanabe T. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun. 2000;272(1):182-185. (Pubitemid 30444919)
17. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999;81(5):739-744.
18. Mezzano D, Munoz X, Martinez C, et al. Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost. 1999;81(6):913-917. (Pubitemid 29312707)
19. de Valk-de Roo GW, Stehouwer CD, Lambert J, et al. Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women. Clin Chem. 1999;45(8 Pt 1):1200-1205. (Pubitemid 29424258)
20. Schreiner PJ, Wu KK, Malinow MR, et al. Hyperhomocysteinemia and hemostatic factors: the Atherosclerosis Risk in Communities study. Ann Epidemiol. 2002;12(4):228-236. (Pubitemid 34428624)
21. Vulin AL, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem. 2004;278(24):25172-25178.
22. Keaney JF Jr, Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23(3):434-439. (Pubitemid 36337219)
23. Urakawa H, Katsuki A, Sumida Y, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88(10):4673-4676. (Pubitemid 37357510)
24. Madebo T, Lindtjorn B, Aukrust P, Berge RK. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Nutr. 2003;78(1):117-122. (Pubitemid 39655256)
25. Thompson HJ, Heimendinger J, Sedlacek S, et al. 8-Isoprostane F2alpha excretion is reduced in women by increased vegetable and fruit intake. Am J Nutr. 2005;82(4):768-776. (Pubitemid 43779689)
26. Lasheras C, Gonzalez S, Huerta JM, et al. Food habits are associated with lipid peroxidation in an elderly population. J Am Diet Assoc. 2003;103(11):1480-1487. (Pubitemid 39220494)
27. Turpeinen AM, Basu S, Mutanen M. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot Essent Fatty Acids. 1998;59(3):229-233. (Pubitemid 28505116)
28. Rajendran S, Parasakthy K, Deepalakshmi PD, Devaraj SN. Oxidative stress in rat liver and lung induced by furanoterpenoids isolated from Fusarium solani infected sweet potatoes. Indiana J Exp Biol. 1996;34:57-60. (Pubitemid 126497804)
29. Sattar N, Murray HM, McConnachie A, et al. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circ. 2007;115(8):981-989.